These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12795343)
1. Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan. Chang FH; Tzeng DS; Lee TM; Chen TC; Hsu LS; Lung FW Kaohsiung J Med Sci; 2003 Apr; 19(4):151-8. PubMed ID: 12795343 [TBL] [Abstract][Full Text] [Related]
2. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan. Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791 [TBL] [Abstract][Full Text] [Related]
3. Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan. Lin HY; Huang CH; Wu WJ; Chou YH; Fan PL; Lung FW Kaohsiung J Med Sci; 2005 Feb; 21(2):57-64. PubMed ID: 15825690 [TBL] [Abstract][Full Text] [Related]
4. Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysis. Pauly M; Schmitz M; Kayser I; Lagoda P; Türeci O; Kerschen A; Weber J; Seitz G; Hentges F; Dicato M Biomed Pharmacother; 1998; 52(5):220-8. PubMed ID: 9755819 [TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
6. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. Fujii S; Fujimori T; Chiba T J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma. Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722 [TBL] [Abstract][Full Text] [Related]
10. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
11. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Eguchi S; Kohara N; Komuta K; Kanematsu T Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566 [TBL] [Abstract][Full Text] [Related]
12. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
13. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478 [TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. Lung FW; Lee TM; Shu BC; Chang FH J Cancer Res Clin Oncol; 2004 Dec; 130(12):728-32. PubMed ID: 15365822 [TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients. Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [TBL] [Abstract][Full Text] [Related]
18. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Soong R; Iacopetta BJ Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735 [TBL] [Abstract][Full Text] [Related]
20. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH. Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]